Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Federal Trade Commission
Cerilliant
Medtronic
Johnson and Johnson
UBS
Harvard Business School
Mallinckrodt
Farmers Insurance

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR COLCHICINE

« Back to Dashboard

Clinical Trials for Colchicine

Trial ID Title Status Sponsor Phase Summary
NCT00000577 Asthma Clinical Research Network (ACRN) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
NCT00004368 Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis Unknown status Children's Hospital Colorado Phase 1 OBJECTIVES: I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.
NCT00004368 Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis Unknown status National Center for Research Resources (NCRR) Phase 1 OBJECTIVES: I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.
NCT00004748 Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis Completed Tufts Medical Center Phase 3 OBJECTIVES: I. Compare the efficacy of low-dose oral pulse methotrexate (MTX) and ursodiol versus colchicine and ursodiol in patients with primary biliary cirrhosis (PBC). II. Determine the optimum dose and duration of MTX treatment. III. Investigate the role of fibrogenic cytokines (FC) in PBC pathogenesis and the effect of treatment on FC production.
NCT00004748 Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis Completed National Center for Research Resources (NCRR) Phase 3 OBJECTIVES: I. Compare the efficacy of low-dose oral pulse methotrexate (MTX) and ursodiol versus colchicine and ursodiol in patients with primary biliary cirrhosis (PBC). II. Determine the optimum dose and duration of MTX treatment. III. Investigate the role of fibrogenic cytokines (FC) in PBC pathogenesis and the effect of treatment on FC production.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Colchicine

Condition Name

Condition Name for Colchicine
Intervention Trials
Gout 18
Pharmacokinetics 13
Healthy 9
Atrial Fibrillation 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Colchicine
Intervention Trials
Gout 20
Inflammation 9
Myocardial Infarction 9
Infarction 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Colchicine

Trials by Country

Trials by Country for Colchicine
Location Trials
United States 321
Canada 20
China 15
France 11
Italy 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Colchicine
Location Trials
California 19
New York 16
North Dakota 15
Florida 15
Texas 14
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Colchicine

Clinical Trial Phase

Clinical Trial Phase for Colchicine
Clinical Trial Phase Trials
Phase 4 23
Phase 3 29
Phase 2/Phase 3 3
[disabled in preview] 35
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Colchicine
Clinical Trial Phase Trials
Completed 72
Recruiting 18
Not yet recruiting 13
[disabled in preview] 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Colchicine

Sponsor Name

Sponsor Name for Colchicine
Sponsor Trials
Mutual Pharmaceutical Company, Inc. 20
Takeda 7
Novartis Pharmaceuticals 7
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Colchicine
Sponsor Trials
Other 101
Industry 54
NIH 12
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Queensland Health
McKinsey
Merck
Citi
Cerilliant
Julphar
Fish and Richardson
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.